There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (3)

Short Titles

Short Titles - House of Representatives

Short Title(s) as Introduced

ACCESS for Biosimilars Act of 2019
Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend title XVIII of the Social Security Act to eliminate cost sharing for biosimilar biological products furnished under part B of the Medicare program.


Actions Overview (1)

Date Actions Overview
10/01/2019Introduced in House

All Actions (5)

Date All Actions
10/02/2019Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
10/01/2019Referred to the Subcommittee on Health.
Action By: Committee on Ways and Means
10/01/2019Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
10/01/2019Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Action By: House of Representatives
10/01/2019Introduced in House
Action By: House of Representatives

Cosponsors (2)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Brindisi, Anthony [D-NY-22]* 10/01/2019
Rep. King, Peter T. [R-NY-2]* 10/01/2019

Committees (2)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
House Energy and Commerce10/01/2019 Referred to
House Energy and Commerce Subcommittee on Health10/02/2019 Referred to
House Ways and Means10/01/2019 Referred to
House Ways and Means Subcommittee on Health10/01/2019 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Subjects (4)


Latest Summary (1)

There is one summary for H.R.4597. View summaries

Shown Here:
Introduced in House (10/01/2019)

Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019 or the ACCESS for Biosimilars Act of 2019

This bill eliminates cost-sharing for biosimilar biological products for certain qualifying beneficiaries under Medicare medical services. Specifically, the bill eliminates cost-sharing for beneficiaries whose coverage under private health insurance, a federal program (other than Medicare), a Medicare supplemental policy, or Medicare Advantage does not already do so. The Centers for Medicare & Medicaid Services must establish a process for determining a beneficiary's eligibility and notifying Medicare Advantage organizations of such determinations.